CTLA4 and cancer: The overexpression of T cell surface proteins known as immune checkpoints (PD-1, cytotoxic T lymphocyte-associated protein 4 (CTLA-4)), which bind to immune response modulator ligands (PD-L1, B7) on the surface of cancer cells and antigen-presenting cells, promotes the ability of cancer cells to escape the immune system [16].